drugset / Trial / NCT07448298
A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, open-label, single-centre exploratory clinical trial designed to evaluate the safety, tolerability, and preliminary efficacy of AFN50 Injection in adult patients with B-cell-mediated refractory/replapased autoimmune diseases.
Timeline
- Start
- 2026-03-09
- Primary completion
- 2028-02-29
- Completion
- 2029-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AFN50 | Unknown | — | Intravenous |
Indications
No indication recorded.